| Pediatric Respiratory Infections |
0 |
0.81 |
| Adenovirus |
0 |
0.71 |
| HIV Infection |
0 |
0.61 |
| Hepatitis C Virus |
0 |
0.58 |
| Hepatitis |
0 |
1 |
| Child |
0 |
0.53 |
| Otolaryngology |
0 |
0.36 |
| COVID-19 |
0 |
0.23 |
| Toxicology |
0 |
0.2 |
| Nasopharyngitis |
0 |
0.12 |
| Cornea and External Disease |
0 |
0.11 |
| Conjunctivitis |
0 |
0.07 |
| Hospital |
0 |
0.06 |
| Outbreak |
0 |
0.06 |
| UK Site Content |
0 |
0.06 |
| Acute Respiratory Distress Syndrome |
0 |
0.04 |
| Organ Transplantation |
0 |
0.04 |
| Rhinorrhea |
0 |
0.04 |
| Vaccines |
0 |
0.04 |
| Alabama |
0 |
0.03 |
| Antiviral Agents |
0 |
0.03 |
| Centers for Disease Control and Prevention |
0 |
0.03 |
| Fever |
0 |
0.03 |
| Grant |
0 |
0.03 |
| Hepatitis A |
0 |
0.03 |
| Immunization |
0 |
0.03 |
| Natural Killer (NK) Cells |
0 |
0.03 |
| Nose |
0 |
0.03 |
| Orbit |
0 |
0.03 |
| Pandemic |
0 |
0.03 |
| Respiratory Syncytial Virus (RSV) Infection |
0 |
0.03 |
| Severe Acute Respiratory Syndrome |
0 |
0.03 |
| Stomach |
0 |
0.03 |
| T-Lymphocyte |
0 |
0.03 |
| Translational Research |
0 |
0.03 |
| Transplantation |
0 |
0.03 |